Earlier this month, Fidson Healthcare Plc was named one of 11 manufacturers in nine countries selected under a voluntary licensing agreement between the Medicines Patent Pool (MPP) and Roche. The licence covers generic baloxavir marboxil, an influenza antiviral. It is subject to regulatory authorisation and extends to 129 countries.
For anyone who follows manufacturing and tax, the question is what this means for the sector and for those who report on it.
How the arrangement works
1. The patent holder grants a voluntary licence to the MPP.
2. The MPP sublicenses selected manufacturers.
3. Each manufacturer develops, produces and supplies the generic within the licensed territories, once the relevant regulator has approved it.
Approval, quality standards and supply terms still apply. A licence opens a door. It does not replace compliance.
Why it matters for manufacturing and export
- It places a Nigerian manufacturer in a global supply chain.
- It supports domestic and regional production capacity.
- It may increase export activity, which raises documentation and reporting requirements.
Tax implications to understand
Under the Nigeria Tax Act, the Nigeria Tax Administration Act and the Nigeria Revenue Service (Establishment) Act, effective 1 January 2026, the Nigeria Revenue Service (NRS) now administers federal taxes. Points relevant to this sector:
- Company income tax: Profits are taxed under the Nigeria Tax Act. Small companies (turnover of ₦100 million or less and fixed assets below ₦250 million) are exempt.
- Development levy: A 4% levy on assessable profits applies to companies other than small and non-resident ones. It consolidates several earlier levies.
- Exports: Profits from goods exported from Nigeria may be exempt from income tax, provided proceeds are repatriated through official channels. Export records therefore carry real weight.
- VAT: Pharmaceutical products are zero-rated, which allows input VAT recovery. Correct classification and documentation are essential.
For the exact wording and current guidance, refer to the NRS (nrs.gov.ng) and the Acts themselves.
Steps to take before considering exposure to this sector
This is general information, not investment advice.
1. Read the primary sources: company disclosures, regulatory announcements and the MPP/Roche licence terms.
2. Check the regulatory status of the product in each target market.
3. Review published financial statements, including cash flow, borrowings and FX exposure.
4. Understand the tax position: the applicable rate, the development levy, VAT treatment and export income conditions.
5. Consider your own objectives and risk tolerance.
6. Consult a licensed financial adviser and a tax professional before acting.
Why every taxpayer should care
Reliable tax compliance supports lawful operation, access to contracts and financing, and fewer penalties. Taxpayers in manufacturing and export face added scrutiny over classification, repatriation and incentives. They should also be aware of the newer reporting and administration rules.
Why monthly bookkeeping matters before tax season
- Year-end figures are only as reliable as the monthly records beneath them.
- Reconciled accounts make VAT, withholding tax and levy computations easier to verify.
- Export proceeds and supporting documents are easier to trace.
- Errors found in month two cost less to fix than errors found at filing.
- Records support claims for incentives and exemptions.
Why use a professional firm
Tax law is changing, and incentives come with conditions. A professional firm can interpret the legislation, review classifications, prepare accurate returns and advise on documentation. The firm works on your behalf, but responsibility for the filings stays with you.
FAQ
1. Is Fidson's selection a tax incentive?
No. It is a licensing arrangement. Tax treatment follows the Nigeria Tax Act and related laws.
2. Are exports automatically tax-free?
No. Exemption depends on meeting the legal conditions, including repatriation through official channels.
3. Do small companies still need to file?
Yes. Exemption from certain taxes does not remove filing and record-keeping obligations.
4. Is pharmaceutical VAT zero-rated?
Pharmaceutical products are zero-rated under the new framework. Confirm the classification of your specific products.
5. Is this post investment advice?
No. It is general information. Seek individual advice.
